Oxalates
Oxalates (oxalic acid, C₂H₂O₄, and its salts) are small organic molecules produced by plants and by human metabolism. They’re the simplest dicarboxylic acid — two carboxylic acid groups bonded directly together. Their potential connection to Mast Cells is the least established of the dietary triggers covered here.
Chemistry and Sources
Oxalic acid readily forms salts with calcium, magnesium, iron, and other divalent cations. Calcium oxalate is famously insoluble — this is the primary component of kidney stones and is the source of most oxalate-related pathology.
High-oxalate foods include spinach, rhubarb, beets, Swiss chard, sweet potatoes, nuts (especially almonds), chocolate, tea, and soy products. Spinach is an outlier — its oxalate content is an order of magnitude higher than most other foods. Oxalate content varies significantly by variety and growing conditions — see Food Science Kit for a measurement-based approach.
The body also produces oxalate endogenously, primarily in the liver, as an end product of glycine, hydroxyproline, and ascorbic acid (vitamin C) metabolism.
Known Pathology: Crystal Deposition
The well-established harm from oxalates involves crystal formation. When oxalate concentrations exceed the solubility threshold, calcium oxalate crystals precipitate in tissues. This is a physical chemistry problem — supersaturation → nucleation → crystal growth.
Sites of crystal deposition include kidneys (nephrolithiasis, nephrocalcinosis), joints, blood vessels, eyes, skin, and bone. The crystals are mechanically irritating — they’re sharp, insoluble, and provoke an inflammatory response.
The Proposed Mast Cell Connection
Here’s where established science gives way to hypothesis:
The irritation hypothesis: Calcium oxalate crystals deposited in tissues may mechanically activate local Mast Cells, similar to how other physical stimuli trigger non-IgE activation. The crystals cause local tissue damage → inflammatory mediator release → mast cell recruitment and activation. This is biologically plausible and is supported by the known inflammatory response to crystal deposition in gout (urate crystals) and pseudogout (calcium pyrophosphate crystals).
The direct activation hypothesis: Some researchers propose that soluble oxalate (not crystals) may directly affect mast cell membrane stability or signaling. Evidence for this is limited and mostly in vitro.
The gut permeability link: Oxalate crystals or high oxalate concentrations in the gut lumen may damage the intestinal epithelium, contributing to Intestinal Permeability, which would increase exposure to other mast cell triggers. This is plausible but not well-studied specifically for oxalates.
Honest assessment of the evidence
The connection between dietary oxalates and mast cell activation is the weakest of the four dietary trigger categories covered in this vault (Dietary Histamine, Histamine Liberators, Salicylates, oxalates). There are plausible mechanisms. Some clinicians report clinical improvement with oxalate restriction in mast cell patients. But controlled studies specifically examining oxalate-mast cell interactions are sparse.
What IS well-established: oxalates cause kidney stones and, in high concentrations, tissue damage. The mast cell angle is an extension that makes mechanistic sense but lacks the evidence base of the histamine and salicylate pathways.
Oxalate Clearance
The body handles oxalate through renal excretion and, importantly, through gut bacteria. Oxalobacter formigenes is a commensal bacterium that metabolizes oxalate in the gut, reducing absorption. Antibiotic use can deplete O. formigenes, increasing oxalate absorption — another example of how the microbiome intersects with inflammatory conditions (see The Gut-Brain-Mast Cell Axis).
Practical Considerations
For someone with MCAS who suspects oxalate sensitivity, the approach would be cautious dietary reduction (not elimination — some oxalate intake is normal) while tracking symptoms. Rapid oxalate reduction can paradoxically cause symptom flares (“oxalate dumping”), as tissue-deposited crystals may mobilize. A gradual reduction is generally recommended by clinicians who work with oxalate sensitivity. Adequate calcium intake helps bind oxalate in the gut, reducing absorption.